Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation ...

The 7.1-magnitude earthquake struck Dingri County in Tibet at 9:05 am local time. At least 95 people have been killed. How ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

JPMorgan's annual survey of 40 executives shows that coverage of popular weight-loss drugs continues to slowly increase ...

Weight loss ... 1 receptor (GLP-1R) agonists (you may know them under such names as Ozempic, Wegovy, Saxenda or Zepbound), these types of drugs have actually been around for about 20 years, having ...

(MENAFN- The Conversation) On the surface, the formula for weight loss seems simple ... scientifically as Glucagon-like peptide 1 receptor (GLP-1R) agonists (you may know them under such names ...

A diabetes medication has become so popular over the internet as a weight loss ... non-diabetics. Health ministry officials are urging caution to those not diagnosed with type 2 diabetes using GLP ...

With one in eight Americans having taken a GLP-1 already — including 43% of those with diabetes and a quarter ... the common barriers that make weight loss so challenging, including the feelings ...